Administrative Guidance against PMDA

PMDA (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareSeptember 14, 2023

Action summary

Company
PMDARomanized
Original: PMDA
Governing law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type
Administrative Guidance
行政指導
Action date
September 14, 2023
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

Thank you for your cooperation in the rapid review and post-marketing safety measures for medical devices and in vitro diagnostic drugs. Following last year, all target review periods for medical devices and in vitro diagnostic drugs were achieved.

Show original Japanese text

医療機器・体外診断用医薬品の迅速な承認審査や市販後安全対策への御協力に感謝申し上げます。昨年度に引き続きまして、医療機器・体外診断用医薬品の審査期間につきましては、目標値を全て達成することができました。

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when PMDA has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
PMDA Romanized
Japanese name
PMDA
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.